InvestorsHub Logo
Followers 1608
Posts 120638
Boards Moderated 3
Alias Born 07/09/2003

Re: RIGATONI post# 35837

Wednesday, 05/04/2005 11:59:09 AM

Wednesday, May 04, 2005 11:59:09 AM

Post# of 91565
~MTDX News...

Motion DNA Addresses IR Phone Calls; Adjusts Record Date for Buyout
PHOENIX, May 4, 2005 /PRNewswire-FirstCall via COMTEX/ --
Motion DNA Corporation (Pink Sheets: MTDX) wishes to address several questions regarding the buyout agreement with Formula 51-2, LLC. Motion DNA has contracted ADP Investor Communication Services(C) to handle the vote and scheduled shareholder meeting.

Motion DNA was informed by ADP Investor Communication Services(C) that the average turnaround time from the record date to the date the shareholder receives their notification has increased to approximately ten (10) to fifteen (15) business days. The company has up to 60 days from the date in which the bid was posted to record a closing date on the acquisition.

Therefore, in order to accurately generate a true shareholder list and report to shareholders via mail the specific information as to how, when and where to exercise a vote on the acquisition, the date of the shareholder meeting has been forced to change. With respect to the lengthiness of this process and with certain events out of the company's control, Motion DNA has set a new meeting date of June 17, 2005.

A NOBO list has been ordered with the record date of Tuesday May 17, 2005, therefore, the last date in which any purchased shares will qualify to vote on the acquisition will be the close of market on Monday, May 16, 2005. All shareholders of record prior to that date are eligible.

According to ADP, once a NOBO list has been generated it takes approximately 3 business days to reach the company (which should be approximately May 21, 2005). Following the receipt of the list, Motion DNA has requested that ADP distribute to each shareholder on the list via mail all instructions regarding the shareholder meeting. ADP states that with their average turnaround time, all proxy statements should arrive approximately between June 2, 2005 and June 6, 2005.

If shares are held by a broker or banker, the meeting notification will be sent to the broker or banker's address of record at which that time they are responsible for relaying the information to their client in a timely manner. If the shares are registered through the transfer agent or in certificate form, the information will be sent to the transfer agent of Motion DNA, at which time they are responsible for relaying the information to the shareholder in a timely manner.

Until and after the acquisition is complete, the company will continue to work towards fulfilling its business plan. Those plans include the finalization of customer contracts, strategic partnerships, new alliances, and product development. In an effort to keep the investment community abreast of happenings, the company is placing a daily update on its website ( www.motiondnacorp.com ) of all on-going transactions regarding the buyout and other business activities. That posting should be active by Friday, May 6.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.

For more information on Motion DNA Contact:
Investor Relations
Motion DNA Corporation
15023 N. 73rd Street
Scottsdale, Arizona 85260
1.877.425.7734 toll free
480.425.7734 phone
480.991.7736 fax
SOURCE Motion DNA Corporation

Investor Relations, Motion DNA Corporation, toll free, +1-877-425-7734, or
+1-480-425-7734, or fax, +1-480-991-7736

http://www.prnewswire.com


--------------------------------------------------------------------------------

Copyright (C) 2005 PR Newswire. All rights reserved.

News provided by





Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.